New Study Shows Value of Treatments Over Time

Spending for 6 of the top 7 causes of death and disease over the last 20 years was cost-effective and improved patient outcomes.

Read the full study now

Engaging Employees in Health Benefit Design

Employees who are meaningfully engaged in deliberating and designing their health care benefits may have a more positive view of their coverage options.

Read the Case Study Now

Getting to the Roots of Health Care Spending

Learn More
Evidence icon

Evidence

How is high-quality, real-world evidence being generated, accepted and used to inform decision-making?
Value icon

Value

Is the value of medicines being recognized as an integral component of care?
Access icon

Access

What can we do to ensure patients have meaningful access to appropriate medications?
Innovation icon

Innovation

How can the health care system support biopharmaceutical innovation that improves patients’ lives?

Featured Content

Comments

NPC Submits Comments on the International Pricing Index Model for Medicare Part B Drugs

In NPC's comments on the International Pricing Index Model for Medicare Part B Drugs, we identify critical methodological limitations associated with the IPI Model, which ultimately undermine the agency’s goal of prioritizing value and improved patient outcomes, over utilization and sickness.

Comments

Events

Webinar: Let’s Get Real: How Will the FDA Framework for RWE Impact You?

Join NPC and key stakeholders on Jan. 30 at 1 p.m. ET for a webinar that will explore the Food and Drug Administration's recently released real-world evidence framework and examine the framework's implications for patients, payers, manufacturers and other health care stakeholders.

Events

Commentary

NPC in Chain Drug Review: Let’s Address Health System Improvements in 2019

In his latest column for Chain Drug Review, National Pharmaceutical Council President and Chief Executive Officer Dan Leonard looks deeper into 2019 and explores how we can take a more holistic approach toward addressing health care spending and getting it under control.

Commentary